Faron Pharmaceuticals
Clinical-stage biopharma developing immunotherapies for cancer patients, led by bexmarilimab, an anti-Clever-1 antibody
Highlights
- New on EvolcAdded 2026-10-28
About Faron Pharmaceuticals
Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on cancer treatments that use the patient's own immune system. Its lead asset, bexmarilimab, is a first-in-class anti-Clever-1 antibody being investigated in a Phase I/II clinical trial in hematological cancers in combination with standard treatments.
The company develops its pipeline from academic discoveries and scientific findings and is listed on AIM (FARN) and First North (FARON).
Faron is headquartered in Turku, Finland, and its team is mostly based in Finland with members across Europe and the UK. The company is hiring through open positions and open applications, and it offers hybrid working and flexible hours.
Product: Bexmarilimab, a first-in-class anti-Clever-1 antibody in Phase I/II trials for hematological cancers and solid tumors.
Jobs at Faron Pharmaceuticals
More biotech & pharma companies
Finncure
Synthetic carrier particles for targeted drug delivery, developed for pharma and biotech partners in FinlandNew on EvolcFinVector
CGMP manufacturer of viral-based gene therapy products in Kuopio, Finland, for pharmaceutical partnersNew on EvolcGalena Pharma
Contract manufacturer of CE-marked medical devices and OTC health products sold as white-label for pharma and healthcare companiesNew on EvolcGencyst
Supplies antibodies, ELISA kits and lab reagents to research labs and runs bioequivalence studies for pharma developersYoung companyNew on EvolcGenevia Technologies
Bioinformatics analysis services for life science researchers and biotech companies, sold per project or as retained expert supportNew on EvolcRemote-friendlyGlucoModicum
Non-invasive, needle-free glucose monitoring for people with diabetes, based on magnetohydrodynamic technologyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Tag Manager
- WordPress
- jQuery
- nginx
